-
2023-504342-55-00
Cohort A:
• Metastatic non-small cell lung carcinoma ( 2023-02-02
-
2022-501004-10-00
Spinocerebellar Ataxia type-3 (SCA3) 2023-01-30
-
2024-518718-14-00
Primary Biliary Cholangitis (PBC) 2023-01-23
-
2024-514352-32-00
Acute ischemic stroke 2023-01-03
-
2024-514602-31-00
aspirin-exacerbated respiratory disease 2022-12-07
-
2024-514714-12-00
Metastatic Pancreatic Ductal Adenocarcinoma 2022-11-11
-
2022-500350-42-01
Prevention of RSV 2022-11-07
-
2024-512244-36-00
Thyroid eye disease (TED) 2022-10-25
-
2024-518250-16-00
Sorbitol Dehydrogenase (SORD) Deficiency 2022-10-20
-
2024-513635-24-00
oesophageal cancer 2022-09-29
-
2023-507208-30-00
Diabetic Macular Edema (DME) 2022-09-20
-
2024-513992-42-00
venous thromboembolism (VTE) in patients with gastroint 2022-09-13
-
2023-509569-19-00
venous thromboembolism (VTE) 2022-08-10
-
2023-508734-34-00
Pulmonary Arterial Hypertension (PAH) 2022-06-30
-
2023-508645-40-00
Bullous Pemphigoid (BP) 2022-05-10
-
2024-516153-52-00
Macrophage activation syndrome (MAS) in the context of 2022-03-28
-
2024-511361-11-00
Advanced dedifferentiated liposarcoma 2022-03-25
-
2023-510428-55-00
Childhood Absence Epilepsy
Juvenile Absence Epilepsy 2022-03-10
-
2024-516608-40-00
Caucasian paediatric kidney transplant recipients 2022-02-23
-
2023-509406-30-00
Patients with HER2-overexpressing advanced or metastati 2022-01-24
-
2023-508173-90-00
Patients with liver tumours that have liver surgery per 2021-11-15
-
2024-516042-18-00
Gastric Carcinoma 2021-09-08
-
2024-513569-38-00
Crohn's Disease 2021-07-09
-
2022-500877-15-00
Pulmonary arterial hypertension (PAH) in one of the fol 2021-06-25